Cognitive change and antipsychotic medications: Results from a pragmatic rater-blind RCT

Cognitive change and antipsychotic medications: Results from a pragmatic rater-blind RCT

Cognitive impairment is a core aspect of psychotic disorders and difficult to treat. Atypical antipsychotics (AAs) might have differential effects on cognitive impairment, but rigid study designs and selective sampling limit the generalizability of existing findings. This pragmatic, semi-randomized,...

Full description

Bibliographic Details
Main Authors: Liss Anda, Erik Johnsen, Rune A. Kroken, Inge Joa, Maria Rettenbacher, Else-Marie Løberg
Format: Article
Language:English
Published: Elsevier 2021-12-01
Series:Schizophrenia Research: Cognition
Subjects:
Antipsychotic medication
Psychosis
Neurocognition
Cognitive
Schizophrenia
RCT
Online Access:http://www.sciencedirect.com/science/article/pii/S2215001321000111

Internet

http://www.sciencedirect.com/science/article/pii/S2215001321000111

Similar Items